Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels

BACKGROUND: Acetylcholinesterase inhibitors (AChE-I) are recommended for the treatment of cognitive symptoms but also of behavioral and psychological symptoms in dementia. They are widely used not only in Alzheimer's disease, but also in other forms of dementia. Efficacy of treatment might depe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortner, Marion, Stange, Marion, Schneider, Heike, Schroeder, Charlotte, Buerger, Katharina, Müller, Claudia, Dorn, Bianca, Goldhardt, Oliver, Diehl-Schmid, Janine, Förstl, Hans, Steimer, Werner, Grimmer, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253642/
https://www.ncbi.nlm.nih.gov/pubmed/32508640
http://dx.doi.org/10.3389/fphar.2020.00691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253642/
https://www.ncbi.nlm.nih.gov/pubmed/32508640
http://dx.doi.org/10.3389/fphar.2020.00691

Ejemplares similares